FIELDS OF INTEREST
Substance use among women and adolescent population
Total number of publications till date > 30

1. Mandal P, Parmar A, Ambekar A, Dhawan A. Substance use among treatment seeking Indian adolescent girls: Are they unique? Asian J Psychiatr. 2019 Mar;41:17-19. doi: 10.1016/j.ajp.2019.03.007. Epub 2019 Mar 6
2. Chawla N, Mandal P, Chatterjee B, Dhawan A. Tramadol associated pica: A case report. Psychiatry clin Neurosci. 2019;73(1):43. doi: 10.1111/pcn.12789. Epub 2018 Dec 2.
3. Mandal P, Dhawan A. Interventions in individuals with specific needs. Indian J Psychiatry2018,60(8): 553-58
4. Dhawan A, Mandal P. Preventive strategies for substance use. Indian J Soc Psychiatry2017,33(2):108-11
5. Ambekar A, Parmar P. Tirthani S, Mandal P. Profile of women substance users seeking treatment at tertiary care treatment centre: A retrospective chart review study. J Subst Use 2017, 22( 5): 507-10.doi.10.1080/14659891.2016.1255792
6. Mandal P, Parmar P. Tirthani S, Ambekar A. Profile of elderly women seeking treatment for substance use disorders at a tertiary care treatment centre. J Subst Use 2017,22(3):353-55.doi.org/10.1080/14659891.2016.1217092
7. Parmar A, Mandal P, Tripathi M, Sagar R Escitalopram Induced Hyponatremia. ASEAN J Psychiatry 2016, 17 (2): 254-57
8. Gupta P, Mandal P, Singh D, Pattanayak RD, Bhargava R, Anju Dhawan A. Detection of Optic Neuropathy and 3-month Follow-up of an Adolescent Inhalant User: Are we Paying Enough Attention? Indian J Psychol Med. 2016; 38(5): 486–88.doi: 10.4103/0253-7176.191390
9. Rao R, Mandal P , Gupta R, Ramshankar P , Mishra A , Ambekar A , Jhanjee S, Dhawan A. Factors Affecting Drug Use During Incarceration: A Cross-Sectional Study of Opioid-Dependent Persons from India. J Subst Abuse Treat. 2016;(61):13–7
10. MandalP,Prakash S."Tramadol: a good option for management of opioid withdrawal syndrome in developing countries." J Subst Use, 2016,21(4) : 339–40
11. Pal A, Parmar A, Mandal P, Sagar R. A case of persistent delusional disorder: Role of dimensions of delusion reappraised. J Mental Health Human Behav. 2016; 21(1): 64-5
12. Mandal P, Jain R, Jhanjee S, Sreenivas V. Psychological Barriers to Tobacco Cessation in Indian Buprenorphine-Naloxone Maintained Patients: A Pilot Study. Indian J Psychol Med. 2015 Jul-Sep; 37(3): 299–304. doi: 10.4103/0253-7176.162944
13. Prakash S, Mandal P. Is dhat syndrome indeed a culturally determined form of depression? Ind J Psychol Med 2015; 37(1):108-9
14. Prakash S, Mandal P. Drug trials in psychiatry: Methodological issues. Asian J Psychiatry. 2014; 8:109-10.
15. Prakash S, Mandal P. Is the DSM-5 position on dhat syndrome justified?Asian J Psychiatry. 2014; 12:155-57.DOI: http://dx.doi.org/10.1016/j.ajp.2014.08.006
16. Prakash S, Mandal P. Psychiatry’s dilemma: A poorly valid symptom based classification versus a yet infantile neuroscience based classification. Asian J Psychiatry. 2014;13:83-4
17. Prakash S, Mandal P. Dhat syndrome: An extremely unusual presentation. World Cul Psych Res Rev World Cultural Psychiatry Research Review 2014; 9 (3): 140-3
18. Prakash S, Mandal P. Medically Unexplained Somatic Symptoms – Diagnostic and Treatment Issues in the Indian Subcontinent. Am J Psychiatry.2014; 171(11):1158-9.
19. Gupta A, Mandal P, Rachna Bhargava R, Pattanayak RD, Sagar R, Dhawan A.Marked Exacerbation of ADHD After Onset of Inhalant Use: A Case Report. J Neuropsychiatry Clin Neurosci. 2014 26(4): E6-E7
20. Mandal P, Prakash S, Sagar R. Primary caregivers of schizophrenia outpatients: burden and its correlates. Delhi Psychiatry J. 2014; 17(2):343-8.
21. Prakash S, Mandal P.Is the DSM-5 position on dhat syndrome justified? Asian J psychiatry. 2014, 27(12):155-7.
22. Mandal P, Prakash S. Stigma of mental disorders and role of nursing professionals: A developing country perspective. J nursing & care. 2014; 3(5):190. http://dx.doi.org/10.4172/2167-1168.1000190
23. Mandal P, Prakash S. Methodological considerations in studying psycho-social aspects of suicide. Ind J psychiatry. 2014; 56 (2):208-9.
24. Prakash S, Mandal P. Improving somatic health in severe mental illness. Acta Psychiatr Scand. 2014; 129(3):236-7.
25. Prakash S, Mandal P. Natural Disasters, Armed Conflict, and Public Health. N Eng J Med. 2014; 370(8):783.
26. Srivastava P, Mandal P, Mehta M, Sagar R. Psychological Intervention in a Case of Bulimia Nervosa: A Case Report. Psychol Studies. 2014; 59(1):68–75.
27. Prakash S, Mandal P. Culture bound syndromes: Nosological and management issues. Ind J Psychiatry 2014; 56(1):99.
28. Mandal P, S. Arumuganathan, Rajesh Sagar, Pakhi Srivastava. A Classical Case of Bulimia Nervosa from India. Indian J Psychol Med .2013; 35 (3): 309-10.
29. Mandal P, Prakash S, Deb KS. Schizophrenia caregivers’ burden: Need to look deeper. Asian J Psychiatry. 2013 Oct; 6(5):428.
30. Mandal P, Pal A, Sagar R. Common mental disorders-A review. J Mental Health Human Behav 2013,8(2):6-14
31. Prakash S, Mandal P, Sagar R. Paroxetine in the treatment of recurrent brief depressive disorder. J Pharmacol Pharmacother. 2013; 4(4): 288–290.
32. Thapa R, Mallick D, Mandal P, Ghosh A. Neuroblastoma masquerading as juvenile idiopathic arthritis. Indian J Pediatrics. 2007; 74(4): 421-422

Abstract published in indexed journals

1. Parmar A, Mandal P, Ambekar A, Dhawan A. Substance use among female adolescents seeking treatment: A study from a tertiary care substance use treatment centre. Indian J Soc Psychiatry. 2018.Accepted for publication
2. Mandal P, Varshney M, Das N, Dhawan A. Profile of adolescent opioid users seeking treatment at a national level addiction treatment centre. Indian J Psychiatry. 2018; 60: S-151
3. Jhanjee S, Jain R, Mandal P. E-cigarettes in adolescents: Issues and challenges. Indian J Soc Psychiatry. 2018; 60:S-43
4. Mandal P, Kuppili PP, Bhargava R, Pattanayak RD, Dhawan A. Clinical profile and retention on pharmacological treatment among opioid dependent adolescents: A retrospective chart review. The Indian J Ped. 2017;SS-1:118
5. Sharma S, Mandal P, Mongia M, Ambekar A. Barriers to Treatment and Psychosocial Complications of Prescription Opioid Dependence in Women in Indian Context: A Case Report and Brief Review. Indian J Soc Psychiatry 2017, 33: S-14

1. Kamran A, Garg H, Varshney M, Agrawal A, Dayal P, Mandal P, Ambekar A. Iatrogenic Opioid Use Disorder In A Young Woman: A Case Report With Unique Clinical Characteristics. Indian J Psychiatry. 2017; 59(S2): 239

1. Shah B, Yadav P, Ambekar A, Mandal P. Gender Sensitive Substance Use Treatment Services: Challenges and Opportunities. Indian J Psychiatry 2016;58(S1): S41
2. Bhargava R, Mandal P, Gupta A, Dhawan A. Psychosocial Determinants of Drop-Out From Treatment At Child & Adolescent Clinic of National Drug Dependence Treatment Centre. Indian J Psychiatry 2016;58(S1): S-121
3. Jhanjee S, Jain R, Chatterjee B, Mandal P. E-Cigarettes Use: Is it an Acceptable Alternative? Indian J Soc Psychiatry 2016.32(4): 386
4. Mandal P, Chatterjee B, Sagar R, Prakash S. Stigma Towards Mentally Ill Among Health Care Staffs in India and Way Forward. Indian J Soc Psychiatry 2016.32(4):413
5. Parmar A, Mandal P, Therthani S, Ambekar A. A Retrospective Chart Review of Female Substance Users Attending Outpatient Clinic at Tertiary Care Drug Dependence Treatment Centre in India. Indian J Soc Psychiatry 2016.32(4):455
6. Kuppili PP, Bhargava R, Mandal P, Mishra AK, Gupta A, Dhawan A. Correlates of treatment retention among children & adolescent substance users seeking treatment in tertiary hospital in North India. Indian J Soc Psychiatry 2016.32(4):459
7. Chatterjee B, Mandal P, Sagar R, Kumar N. Attitude towards mentally ill among nursing Professionals: Evidence from a Tertiary Care General Hospital. Indian J Psychiatry 2015;57(S): 92
8. Krishnan V, Ambekar A, Mandal P, Rao R, Mishra AK. Outcomes on buprenorphine-naloxone at a tertiary care substance use facility: a retrospective chart review. Indian J Psychiatry 2015;57(S):102
9. Jhanjee S, Mandal P, Singh D. Tobacco use in opioid-dependent patients on buprenorphine-naloxone treatment. Ind J Psychiatry Jan 2014; 56 (Suppl 1): S19–S20
10. Mandal P, Jain R, Jhanjee S, Sreenivas V. Barriers of tobacco cessation among Indian buprenorphine-naloxone maintained patients. Alcohol alcohol. 2014; 49(suppl1): i6.doi: 10.1093/alcalc/agu052.19
11. Chatterjee B, Sagar R, Mandal P, Kumar N. Mental illness: Who do the professional blame? Ind J Psychiatry Jan 2013; 55(S 1): S61–S62

Abstracts published in conference abstract book/ International abstract data base

1. Mandal P. E-cigarette use: what is the raging debate? In: The proceedings of World congress of Mental Health.2017 November 2-5;New Delhi, India.
2. Mandal P. Women and drug use: addressing the treatment needs. In: Abstracts of First national conference on Addiction Psychiatry; 2017 November 27-29;New Delhi, India.
3. Chawla N, Mandal P, Chatterjee B, Dhawan A. Tramadol induced pica. In: Abstracts of First national conference on Addiction Psychiatry; 2017 November 27-29;New Delhi, India
   
4. Mandal P. The role of the glutamate and cannabinoid neurotransmitter systems in the nicotine dependence and their treatment implications. In abstracts of 34^th Annual meeting of Indian Academy of Neurosciences; 2016 October 19-21; National Brain Research Centre, Manesar, India
5. Mandal P, Dhawan A, Bhargava R, Sharma S. A retrospective study of factors associated with management of adolescent substance use. In: the proceedings of the 7th Congress of the Asian Society for Child and Adolescent Psychiatry and Allied Professions (ASCAPAP) 2013 September 14-18, New Delhi, India
   
6. Mandal P, Chatterjee B, , Rakesh VR, Kumar N, Sagar R. Community Attitude towards Mentally and Their Treatment among Nursing Professionals in a Tertiary Care General Hospital. In: Abstracts of the 4^th World Congress of Asian Psychiatry; 2013 August 20-23; Bangkok, Thailand
7. Mandal P, Jain R, Jhanjee S, Sreenivas V. Tobacco use in opioid-dependent subjects on buprenorphine-naloxone maintenance treatment. In: Abstract database of NIDA International forum 2013. June 14 -17;San Diego, USA

Presentations made at scientific meetings/ conferences/ workshops
International

1. 1. 22^nd World Congress of Social Psychiatry, 2016 November 30-December 4, New Delhi, India
   2. The 16^th International Society of Addiction Medicine Annual Meeting, 2014 October 2-6, Yokohama, Japan
   3. 7th Congress of the Asian Society for Child and Adolescent Psychiatry and Allied Professions (ASCAPAP) 2013 September 25-28, New Delhi, India
   4. NIDA International forum; 2013 June 14 -17;San Diego, CA, USA
   5. 4^th World Congress of Asian Psychiatry; 2013 August 20-23; Bangkok, Thailand

National

1. First National conclave on Psychological trauma, Child protection and Mental Health, 2018 March 27-28; New Delhi, India.
2. First national conference on Addiction Psychiatry, 2017 November 27-29;New Delhi, India
3. Annual National conference on Addiction Psychology. 2017 September 7-8, Ghaziabad, India
4. 34^th Annual meeting of Indian Academy of Neurosciences; 2016 October 19-21; National Brain Research Centre, Manesar, India
5. 12th Biennial Conference of the Indian Association for Child and Adolescent Mental Health, 2013 September 25-28, New Delhi, India
6. 65^th Annual National Conference of Indian Psychiatric Society. 2013 January 10-13, NIMHANS, Bangalore, India
7. 64^th Annual National Conference of Indian Psychiatric Society. 2012 January 19-22, Kochi, India
8. 63^rd Annual National Conference of Indian Psychiatric Society. 2011 January 16-18, New Delhi, India
9. 62^nd Annual National Conference of Indian Psychiatric Society. 2010 January 17-20, Jaipur, India

Invited Lectures/ CME

1. Delivered invited lecture titled "Women in addiction; issues, concerns and service gaps" in the 7th National Federation of Indian NGOs for Drug Abuse prevention (FINGODAP) conferenceon 30th March, 2019, in Delhi
2. Training of Medical Officers of NCT of Delhi on management of Adolescent Substance Use on 23^rd January and 2^nd Februay, 2018
3. Training of teachers of senior schools under Jamia Milia Islamia on “Skills of dealing with Adolescents facing substance abuse” on 22^nd December, 2017
4. Delivered invited lecture titled “Gender sensitive interventions: An overview” in the national CME on “Emerging Issues in Substance Use Disorders” on 22^nd July, 2017 at NAMS Auditorium, New Delhi
5. Training session on substance abuse problem for police personnel from Central Detective Training School, Ghaziabad on7.3.2017 at NDDTC
6. Organized symposium on “Women and drug use” on 14^th annual day NDDTC on 13^th April,2017 . The title of presentation was “Addiction treatment services for women: a need of the hour”
   

1. Funded projects
   Principal investigator for the project titled “Psycho-social correlates of drug use among attendees of Women’s Clinic of National Drug Dependence treatment Centre” under AIIMS Intramural funding ( 2017)

1. ICMR financial assistance for MD thesis (2009)
2. ICMR (International travel award) (2013)
3. National Institute of Drug Abuse (Early career investigator poster award) (2013)
4. World Congress of Asian Psychiatry- Travel award (2013)
5. CSIR- Travel award (2013)
6. ICMR-Travel award (2013)
7. DST- Travel Award (2014)
8. WHO-ISAM Grants-In-Aid-Of-Travel Fellowship -International Society of Addiction Medicine (2014)

21^st Annual Meeting of International Society of Addiction Medicine to be held in New Delhi, India from 13^th to 16^th November 2019. The theme of the conference is "Addiction in a Rapidly Changing World". We look forward to this opportunity to meet colleagues for shared learning, and a rich social and cultural experience. The conference is being organised by the Department of Psychiatry & National Drug Dependence Treatment Centre (NDDTC), All India Institute of Medical Sciences (AIIMS), New Delhi, India.

Key dates

Proposal Submission deadline for Symposium/ Workshop: 30th April, 2019 (Midnight; Indian Standard Time)

Abstract Submission deadline for Oral Communication / Posters: 30th June, 2019 (Midnight; Indian Standard Time)

Please click here for detail

NDDTC, AIIMS celebrates its 16th Annual Day on 15^th April 2019

The 16th Annual Day of National Drug Dependence Treatment Centre (NDDTC), All India Institute of Medical Sciences (AIIMS), New Delhi was celebrated at NDDTC, Ghaziabad on 16th April 2019.  Mr. Deves Deval, Director, DDAP, MOH&FW; Prof.RandeepGuleria, Director, AIIMS, New Delhi,  Dr. DK Sharma, MS, AIIMS, New Delhi. Mr. Veerendra Mishra, Director, NISD were the dignitaries for the function. Prof (Dr.) Rakesh Chadda, Chief NDDTC and Head Department of Psychiatry, AIIMS presented the Annual Report for the year 2018- 2019 highlighting the achievements of the centre. Organizing Secretary, Prof(Dr.) Atul Ambekar presented the findings of recently conducted 2^nd“National Drug Use Survey of India”. Textbook of “Basics of Addiction Psychology” was also released on this occasion.

AIIMS, New Delhi launches India’s first ever Mobile Methadone Dispensing Van

The National Drug Dependence Treatment Centre (NDDTC), AIIMS has initiated a new service – delivery of methadone through a mobile van in East Delhi. The new service delivery was inaugurated by the AIIMS Director, Prof. Randeep Guleria on 22 March 2019 in the presence of officers from National AIDS Control Organisation (NACO), United Nations Office on Drugs and Crime (UNODC), and the Director General Health Services, Govt. of Delhi. Representatives from NGOs, and drug user community also attended the inauguration event.
Opioid Addiction is a significant problem in India. The recently released report of National Survey last month estimated that India has about 28 Lakh people affected by addiction to opioids such as heroin, opium and various pharmaceutical products. These people require medicines such as methadone or buprenorphine for treatment of opioid addiction. However, there are very few treatment centres providing these medicines, while the need is very high. It is estimated that less than two percent of the population addicted to opioids in India is receiving this treatment, which is recommended by various UN bodies and the World Health Organization (WHO).
Since methadone is a highly regulated medicine it is only provided as daily observed treatment. This medicine is available in just about a dozen cities in India. “Patients often find it difficult to come to the clinic daily to receive methadone, which leads to patients dropping-out of treatment midway”, informed Dr. Ravindra Rao, in-charge of the methadone clinic. The mobile methadone dispensing unit plans to bridge this gap and improve retention of patients into treatment enabling them to work and lead a healthier life. Currently, such dispensing vans or buses are available in few select developed countries in the world, such as USA, Portugal, Spain, Canada and Netherlands. With the launch of mobile delivery of methadone, India joins this elite club. In fact, India is the first country in the South Asian Region to initiate these services.
The van will be parked at strategic places in East Delhi and adjoining areas for fixed time period in the day, where the patients can come and receive their medicine without having to travel to the main clinic. “In the trial run for last two weeks we already have more than two dozen patients enrolled in the facility and the response is very encouraging” informed Dr. Rao. This number is expected to reach about 100 patients per day, very soon. Based on the success of this initiative, this new approach can be scaled-up in different parts of the country.

For Detail Please Click Here